Publication | Closed Access

Empagliflozin Significantly Prevents the Doxorubicin-induced Acute Cardiotoxicity via Non-antioxidant Pathways

InflammationAnti-inflammatoryCardiovascular DiseaseMedicineLipid PeroxidationPhysiologyEmpagliflozin SignificantlyCardiovascular PharmacologyCell DeathPharmacotherapyReactive Oxygen SpecieCardiovascular ToxicityPharmacologyRedox BiologyOxidative Stress